| Year |
Citation |
Score |
| 2023 |
Nemes K, Benesch M, Kolarova J, Johann P, Hasselblatt M, Thomas C, Bens S, Glaser S, Ammerpohl O, Liaugaudiene O, Sadeghipour A, von der Weid N, Schmid I, Gidding C, Erdreich-Epstein A, et al. Rhabdoid tumors in patients conceived following ART: is there an association? Human Reproduction (Oxford, England). PMID 37553222 DOI: 10.1093/humrep/dead154 |
0.35 |
|
| 2021 |
Elghetany MT, Ho JM, Shi-Qi LH, Karthik S, Su JMF, Lin Q, Du Y, Shen J, Chow WY, Lau CC, Adesina A, Major A, Erdreich-Epstein A, Hui KM, Li XN, et al. Maximizing the potential of aggressive mouse tumor models in preclinical drug testing. Scientific Reports. 11: 11580. PMID 34079014 DOI: 10.1038/s41598-021-91167-6 |
0.411 |
|
| 2020 |
Xue Y, Zhu X, Meehan B, Venneti S, Martinez D, Morin G, Itoua Maïga R, Chen H, Papadakis AI, Johnson RM, O'Sullivan MJ, Erdreich-Epstein A, Gotlieb WH, Park M, Judkins AR, et al. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of Pathology. PMID 32558936 DOI: 10.1002/Path.5493 |
0.332 |
|
| 2020 |
Gujar H, Zhang L, Li H, Otani H, Weisenberger DJ, Erdreich-Epstein A, Liang G. Abstract 462: The mutated chromatin modifier gene, H3F3AK27M, is a druggable target of DNA hypomethylating agents in pediatric high-grade glioma Cancer Research. 80: 462-462. DOI: 10.1158/1538-7445.Am2020-462 |
0.361 |
|
| 2019 |
Pathania AS, Ren X, Mahdi MY, Shackleford GM, Erdreich-Epstein A. GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis. Scientific Reports. 9: 13902. PMID 31554835 DOI: 10.1038/S41598-019-50157-5 |
0.423 |
|
| 2019 |
Shackleford GM, Mahdi MY, Moats RA, Hawes D, Tran HC, Finlay JL, Hoang TQ, Meng EF, Erdreich-Epstein A. Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma. Plos One. 14: e0206394. PMID 30608927 DOI: 10.1371/Journal.Pone.0206394 |
0.407 |
|
| 2019 |
Pathania AS, Ren X, Mahdi M, Shackleford GM, Erdreich-Epstein A. Abstract 2053: Targeting GRK2 increases chemotherapy-induced apoptosis in medulloblastoma Cancer Research. 79: 2053-2053. DOI: 10.1158/1538-7445.Sabcs18-2053 |
0.465 |
|
| 2019 |
Ren X, Hirsh E, Mahdi M, Ito F, Chen X, Shackleford G, Erdreich-Epstein A. CSIG-29. STRUCTURAL AND FUNCTIONAL STUDIES OF PID1, A NOVEL GROWTH SUPPRESSOR IN BRAIN TUMORS Neuro-Oncology. 21: vi50-vi50. DOI: 10.1093/Neuonc/Noz175.199 |
0.476 |
|
| 2019 |
Ho J, Karthik S, M.F. Su J, Lin Q, Du Y, Shen J, Chow W, Lau CC, Adekunle A, Major A, Erdreich-Epstein A, Elghetany MT, Hui K, Li X, Teo W. ATRT-06. ISPINESIB IS AN EFFICACIOUS THERAPEUTIC AGENT FOR ATYPICAL TERATOID RHABDOID TUMORS Neuro-Oncology. 21: ii64-ii64. DOI: 10.1093/Neuonc/Noz036.005 |
0.415 |
|
| 2017 |
Erdreich-Epstein A, Singh AR, Joshi S, Vega FM, Guo P, Xu J, Groshen S, Ye W, Millard M, Campan M, Morales G, Garlich JR, Laird PW, Seeger RC, Shimada H, et al. Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. 8: 52193-52210. PMID 28881723 DOI: 10.18632/Oncotarget.13386 |
0.658 |
|
| 2017 |
Xu J, Ren X, Pathania AS, Fernandez GE, Tran A, Zhang Y, Moats RA, Shackleford GM, Erdreich-Epstein A. PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. Scientific Reports. 7: 835. PMID 28400607 DOI: 10.1038/S41598-017-00947-6 |
0.671 |
|
| 2017 |
Erdreich-Epstein A, Ren X. Abstract 3331: PID1, a candidate tumor suppressor in pediatric and adult brain tumors, is a novel interacting partner for a cell surface receptor Cancer Research. 77: 3331-3331. DOI: 10.1158/1538-7445.Am2017-3331 |
0.514 |
|
| 2017 |
Martirosian V, Deshpande K, Shackelford G, Julian A, Lin M, Erdreich-Epstein A, Chen T, Neman J. MEDU-05. THE ROLE OF GABA METABOLISM IN MEDULLOBLASTOMA Neuro-Oncology. 19: iv38-iv38. DOI: 10.1093/Neuonc/Nox083.156 |
0.331 |
|
| 2016 |
Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, ... ... Erdreich-Epstein A, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30: 891-908. PMID 27960086 DOI: 10.1016/J.Ccell.2016.11.003 |
0.407 |
|
| 2016 |
Erdreich-Epstein A, Singh AR, Joshi S, Vega FM, Guo P, Xu J, Groshen S, Ye W, Millard M, Campan M, Morales G, Garlich JR, Laird PW, Seeger RC, Shimada H, et al. Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. PMID 27907905 DOI: 10.18632/oncotarget.13386 |
0.626 |
|
| 2016 |
Yadav VN, Zamler D, Baker GJ, Kadiyala P, Erdreich-Epstein A, DeCarvalho AC, Mikkelsen T, Castro MG, Lowenstein PR. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study. Oncotarget. PMID 27863376 DOI: 10.18632/Oncotarget.13295 |
0.548 |
|
| 2016 |
Shackleford GM, Shi XH, Swanson KS, Mahdi MY, Gonzalez-Gomez I, Asgharzadeh S, D'Apuzzo M, Erdreich-Epstein A, Moats RA. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. Plos One. 11: e0156907. PMID 27310018 DOI: 10.1371/Journal.Pone.0156907 |
0.445 |
|
| 2016 |
Wong K, Opimo AB, Olch AJ, All S, Waxer JF, Clark D, Cheng J, Chlebik A, Erdreich-Epstein A, Krieger MD, Tamrazi B, Dhall G, Finlay JL, Chang EL. Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature. CurēUs. 8: e585. PMID 27239400 DOI: 10.7759/Cureus.585 |
0.519 |
|
| 2016 |
Meade JC, Moore ZR, Stuart SH, Cholka A, Boriack RL, Xu J, Erdreich-Epstein A, Rakheja D, Boothman DA, Amatruda JF, Laetsch TW. Abstract B39: NQO1 as a therapeutic target for atypical teratoid/ rhabdoid tumor Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-B39 |
0.643 |
|
| 2016 |
Erdreich-Epstein A, Ren X, Robinson S, Frey M. CSIG-30. A NOVEL INTERACTING PARTNER FOR PID1, A GROWTH INHIBITOR IN PEDIATRIC AND ADULT BRAIN TUMORS Neuro-Oncology. 18: vi47-vi47. DOI: 10.1093/Neuonc/Now212.191 |
0.428 |
|
| 2015 |
Xu J, Margol AS, Shukla A, Ren X, Finlay JL, Krieger MD, Gilles FH, Couch FJ, Aziz M, Fung ET, Asgharzadeh S, Barrett MT, Erdreich-Epstein A. Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia. Frontiers in Oncology. 5: 191. PMID 26380221 DOI: 10.3389/Fonc.2015.00191 |
0.604 |
|
| 2015 |
Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, et al. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. Neuro-Oncology. PMID 26254476 DOI: 10.1093/Neuonc/Nov097 |
0.33 |
|
| 2015 |
Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, et al. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 6: 3165-77. PMID 25638158 DOI: 10.18632/Oncotarget.3078 |
0.681 |
|
| 2015 |
Kaur H, Hütt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, Weissman BE, Eberhart CG, Raabe EH. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. 74: 177-85. PMID 25575139 DOI: 10.1097/Nen.0000000000000161 |
0.674 |
|
| 2015 |
Margol AS, Robison NJ, Gnanachandran J, Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein A, Krieger MD, Drissi R, Fouladi M, Gilles FH, Judkins AR, Sposto R, et al. Tumor-associated macrophages in SHH subgroup of medulloblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1457-65. PMID 25344580 DOI: 10.1158/1078-0432.Ccr-14-1144 |
0.46 |
|
| 2015 |
Chakravadhanula M, Hampton CN, Chodavadia P, Ozols V, Zhou L, Catchpoole D, Xu J, Erdreich-Epstein A, Bhardwaj RD. Wnt pathway in atypical teratoid rhabdoid tumors. Neuro-Oncology. 17: 526-35. PMID 25246426 DOI: 10.1093/Neuonc/Nou229 |
0.638 |
|
| 2015 |
Xu J, Margol A, Asgharzadeh S, Erdreich-Epstein A. Pediatric brain tumor cell lines. Journal of Cellular Biochemistry. 116: 218-24. PMID 25211508 DOI: 10.1002/Jcb.24976 |
0.66 |
|
| 2015 |
Moore ZR, Stuart S, Cholka A, Venkataraman A, Xu J, Erdreich-Epstein A, Rakheja D, Boothman DA, Amatruda JF, Laetsch TW. Abstract 1613: β-lapachone: a novel targeted therapy for atypical teratoid rhabdoid tumors (ATRTs) Cancer Research. 75: 1613-1613. DOI: 10.1158/1538-7445.Am2015-1613 |
0.371 |
|
| 2015 |
Shackleford G, Mahdi M, Ren X, Moats R, Erdreich-Epstein A. PTPS-05PID1 NEGATIVELY REGULATES GROWTH OF INTRACRANIAL MEDULLOBLASTOMAS IN VIVO IN BarTeL MICE Neuro-Oncology. 17: v180.1-v180. DOI: 10.1093/Neuonc/Nov228.05 |
0.409 |
|
| 2015 |
Xu J, Ren X, Shackleford GM, Moats R, Erdreich-Epstein A. BI-04 * PID1 IS A CHEMOTHERAPY SENSITIZER AND CANDIDATE TUMOR SUPPRESSOR IN MEDULLOBLASTOMA Neuro-Oncology. 17: iii3-iii3. DOI: 10.1093/Neuonc/Nov061.10 |
0.669 |
|
| 2014 |
Nandhu MS, Hu B, Cole SE, Erdreich-Epstein A, Rodriguez-Gil DJ, Viapiano MS. Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas. Cancer Research. 74: 5435-48. PMID 25139440 DOI: 10.1158/0008-5472.Can-14-0685 |
0.508 |
|
| 2014 |
Lee JS, Xiao J, Patel P, Schade J, Wang J, Deneen B, Erdreich-Epstein A, Song HR. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1. Neuro-Oncology. 16: 191-203. PMID 24305710 DOI: 10.1093/Neuonc/Not167 |
0.515 |
|
| 2014 |
Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB, Schur M, Gilles FH, Ji L, Malvar J, Shackleford GM, Margol AS, Krieger MD, Judkins AR, Jones DT, et al. PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 827-36. PMID 24300787 DOI: 10.1158/1078-0432.Ccr-13-2053 |
0.684 |
|
| 2014 |
Xu J, Ren X, Tran A, Shackleford GM, Erdreich-Epstein A. Abstract 3975: PID1, a new growth-inhibitory gene, sensitizes brain tumor cell lines to chemotherapy Cancer Research. 74: 3975-3975. DOI: 10.1158/1538-7445.Am2014-3975 |
0.699 |
|
| 2014 |
Xu J, Ren X, Tran A, Erdreich-Epstein A. CB-19 * PID1, A NEW GROWTH-INHIBITORY GENE, SENSITIZES MEDULLOBLASTOMA AND GLIOMA CELL LINES TO CHEMOTHERAPY Neuro-Oncology. 16: v44-v44. DOI: 10.1093/Neuonc/Nou241.18 |
0.677 |
|
| 2014 |
Erdreich-Epstein A, Xu J, Ren X. PID1 IS A NOVEL SENSITIZER OF BRAIN TUMOR CELLS TO CHEMOTHERAPY Neuro-Oncology. 16: iii26-iii26. DOI: 10.1093/Neuonc/Nou208.11 |
0.689 |
|
| 2013 |
Erdreich-Epstein A, Ren X, Zhou H, Sposto R, Ji L, Pfister S, Kool M, Asgharzadeh S. Abstract 3825: Inhibitory effect of PID1 in medulloblastomas, gliomas and ATRT. Cancer Research. 73: 3825-3825. DOI: 10.1158/1538-7445.Am2013-3825 |
0.447 |
|
| 2013 |
Woodburn T, Hall HA, White K, Calderon R, Blaydes R, Farooqi A, Hogarty M, Mosse Y, Maris J, Erdreich-Epstein A, Miller B, Reynolds CP. Abstract 2786: Establishing validated pediatric cancer cell lines and direct xenografts from post-mortem samples. Cancer Research. 73: 2786-2786. DOI: 10.1158/1538-7445.Am2013-2786 |
0.463 |
|
| 2012 |
Ren X, Xu J, Cooper JP, Kang MH, Erdreich-Epstein A. c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5. Plos One. 7: e42291. PMID 22879933 DOI: 10.1371/Journal.Pone.0042291 |
0.555 |
|
| 2012 |
Ridgway LD, Wetzel MD, Ngo JA, Erdreich-Epstein A, Marchetti D. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells. Molecular Cancer Research : McR. 10: 689-702. PMID 22513363 DOI: 10.1158/1541-7786.Mcr-11-0534 |
0.414 |
|
| 2012 |
Xu J, Erdreich-Epstein A, Gonzalez-Gomez I, Melendez EY, Smbatyan G, Moats RA, Rosol M, Biegel JA, Reynolds CP. Novel cell lines established from pediatric brain tumors. Journal of Neuro-Oncology. 107: 269-80. PMID 22120608 DOI: 10.1007/S11060-011-0756-5 |
0.66 |
|
| 2012 |
Gozali AE, Britt B, Shane L, Gonzalez I, Gilles F, McComb JG, Krieger MD, Lavey RS, Shlien A, Villablanca JG, Erdreich-Epstein A, Dhall G, Jubran R, Tabori U, Malkin D, et al. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatric Blood & Cancer. 58: 905-9. PMID 21990040 DOI: 10.1002/Pbc.23349 |
0.36 |
|
| 2012 |
Erdreich-Epstein A, Ren X, Zhou H, Schur M, Ji L, Sposto R, Asgharzadeh S. Abstract 4334: Expression of PID1 correlates with PFS in pediatric medulloblastomas and negatively impacts growth of medulloblastoma, glioblastoma and AT/RT brain tumor cell lines Cancer Research. 72: 4334-4334. DOI: 10.1158/1538-7445.Am2012-4334 |
0.563 |
|
| 2011 |
Chaitanya GV, Cromer WE, Wells SR, Jennings MH, Couraud PO, Romero IA, Weksler B, Erdreich-Epstein A, Mathis JM, Minagar A, Alexander JS. Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro. Journal of Neuroinflammation. 8: 162. PMID 22112345 DOI: 10.1186/1742-2094-8-162 |
0.327 |
|
| 2011 |
Parekh C, Jubran R, Erdreich-Epstein A, Panigrahy A, Bluml S, Finlay J, Dhall G. Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. Journal of Neuro-Oncology. 103: 673-80. PMID 21038110 DOI: 10.1007/S11060-010-0444-X |
0.307 |
|
| 2010 |
Song HR, Gonzalez-Gomez I, Suh GS, Commins DL, Sposto R, Gilles FH, Deneen B, Erdreich-Epstein A. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro-Oncology. 12: 122-32. PMID 20150379 DOI: 10.1093/Neuonc/Nop044 |
0.412 |
|
| 2010 |
Xu J, Millard M, Ren X, Cox OT, Erdreich-Epstein A. c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 and by disruption of actin. Blood. 115: 2709-18. PMID 20124512 DOI: 10.1182/Blood-2009-05-223776 |
0.574 |
|
| 2010 |
Xiong G, Husseiny MI, Song L, Erdreich-Epstein A, Shackleford GM, Seeger RC, Jäckel D, Hensel M, Metelitsa LS. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. International Journal of Cancer. Journal International Du Cancer. 126: 2622-34. PMID 19824039 DOI: 10.1002/Ijc.24957 |
0.359 |
|
| 2009 |
Rosol M, Harutyunyan I, Xu J, Melendez E, Smbatyan G, Finlay JL, Krieger MD, Gonzalez-Gomez I, Reynolds CP, Nelson MD, Erdreich-Epstein A, Blüml S. Metabolism of orthotopic mouse brain tumor models. Molecular Imaging. 8: 199-208. PMID 19728974 DOI: 10.2310/7290.2009.00019 |
0.631 |
|
| 2009 |
Butturini AM, Jacob M, Aguajo J, Vander-Walde NA, Villablanca J, Jubran R, Erdreich-Epstein A, Marachelian A, Dhall G, Finlay JL. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Cancer. 115: 2956-63. PMID 19402050 DOI: 10.1002/cncr.24341 |
0.331 |
|
| 2007 |
Rosenne E, Shakhar G, Melamed R, Schwartz Y, Erdreich-Epstein A, Ben-Eliyahu S. Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis. Brain, Behavior, and Immunity. 21: 395-408. PMID 17240115 DOI: 10.1016/J.Bbi.2006.12.002 |
0.382 |
|
| 2007 |
Finlay JL, Erdreich-Epstein A, Packer RJ. Progress in the treatment of childhood brain tumors: no room for complacency. Pediatric Hematology and Oncology. 24: 79-84. PMID 17130118 DOI: 10.1080/08880010601001073 |
0.467 |
|
| 2006 |
Erdreich-Epstein A, Ganguly AK, Shi XH, Zimonjic DB, Shackleford GM. Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation. Genes, Chromosomes & Cancer. 45: 169-81. PMID 16252261 DOI: 10.1002/Gcc.20280 |
0.418 |
|
| 2006 |
Aguayo J, Teplick A, Butturini A, Erdreich-Epstein A, Jubran R, Villablanca J, Hyder D, Britt B, Finlay J. Factors affecting event free survival (EFS) after high dose chemotherapy with stem cell rescue (HDC/SCR) in children with brain tumors Journal of Clinical Oncology. 24: 9057-9057. DOI: 10.1200/Jco.2006.24.18_Suppl.9057 |
0.451 |
|
| 2005 |
Erdreich-Epstein A, Tran LB, Cox OT, Huang EY, Laug WE, Shimada H, Millard M. Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways. Blood. 105: 4353-61. PMID 15705795 DOI: 10.1182/Blood-2004-08-3098 |
0.374 |
|
| 2003 |
Perelman N, Selvaraj SK, Batra S, Luck LR, Erdreich-Epstein A, Coates TD, Kalra VK, Malik P. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood. 102: 1506-14. PMID 12714517 DOI: 10.1182/Blood-2002-11-3422 |
0.306 |
|
| 2002 |
Erdreich-Epstein A, Tran LB, Bowman NN, Wang H, Cabot MC, Durden DL, Vlckova J, Reynolds CP, Stins MF, Groshen S, Millard M. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. The Journal of Biological Chemistry. 277: 49531-7. PMID 12388538 DOI: 10.1074/Jbc.M209962200 |
0.397 |
|
| 2002 |
Erdreich-Epstein A, Monforte HL, Lavey RS, Joshi S, Phillips JD, Villablanca JG. Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary. Journal of Pediatric Hematology/Oncology. 24: 229-33. PMID 11990313 DOI: 10.1097/00043426-200203000-00015 |
0.408 |
|
| 2001 |
Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A, DeClerck YA. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin Cancer Research. 61: 5587-5594. PMID 11454712 |
0.353 |
|
| 1999 |
Joshi S, Phillips JD, Lavey RS, Monforte HL, Villablanca JG, Erdreich-Epstein A. #409 Myeloablative therapy with ABMT and local radiation in the successful treatment of recurrent advanced stage juvenile granulosa cell tumor of the ovary Journal of Pediatric Hematology/Oncology. 21: 324. DOI: 10.1097/00043426-199907000-00080 |
0.391 |
|
| 1998 |
Izadi KD, Erdreich-Epstein A, Liu Y, Durden DL. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcγRII signaling Experimental Cell Research. 245: 330-342. PMID 9851874 DOI: 10.1006/Excr.1998.4259 |
0.305 |
|
| 1998 |
Erdreich-Epstein A, Shackleford GM. Differential expression of Wnt genes in normal and flat variants of PC12 cells, a cell line responsive to ectopic Wnt1 expression Growth Factors. 15: 149-158. PMID 9505170 DOI: 10.3109/08977199809117190 |
0.327 |
|
| 1997 |
Erdreich-Epstein A, Liu M, Liu Y, Durden DL. Protein tyrosine phosphatase inhibitors in FcγRI-induced myeloid oxidant signaling Experimental Cell Research. 237: 288-295. PMID 9434624 DOI: 10.1006/Excr.1997.3795 |
0.317 |
|
| 1997 |
Erdreich-Epstein A, Song P, Gomez IG, Durden DL. #513 Integrin a v,B 3 is expressed on angiogenic endothelial cells in malignant pediatric brain tumors Journal of Pediatric Hematology/Oncology. 19: 366. DOI: 10.1097/00043426-199707000-00047 |
0.369 |
|
| Show low-probability matches. |